Latest News
-
25% Dividend Record Date: Logistic Stock Nears 1-Year High And It Belongs To Mahindra; Motilal Neutral -
1:10 Split, 26 Dividends: Tata's 26-Year-Old Retail Stock In Focus, Q4, Dividend Ahead; Buy For Target Rs 4200 -
1:5 Split Soon: Rs 2,300 Defence Stock To Split Into Five Shares, Rs 400 Cr Fundraising Too; Hits 52-Week High -
Penny Stock Bags Back-To-Back Orders Worth Rs 500 Mn, 110 Mn; Shares Hit Upper Circuit -
Marshall Wace Offloads Stakes in 21 Indian Companies for Rs 2,365 Crore -
Rishi Sunak Announces Generational Hike in UK Defence Spending -
Dr Reddy's Issues Recall for Six Drug Lots in US Over Subpotency Concerns -
Dr Reddy's Voluntarily Recalls Six Drug Lots in US Over Potency Concerns -
IRCON, RITES: 2 Multibagger Navratna Railway Stocks Potential To 17-24% Upside Ahead; Assigned BUY Rating -
AU Small Finance Bank Unveils New Products Including Rupay Credit Card
For Daily Alerts
Cipla subsidiary acquires Celeris
Pharma major, Cipla in a notice to the Bombay Stock Exchange has said that Cipla Holding B.V., a wholly owned subsidiary of the Company, has acquired 100 per cent stake in Celeris d.o.o., Croatia.
Celeris d.o.o. is the distributor of Company's products in Croatia. Cipla Ltd is one of the world's largest generic companies. The company has over 2,000 products, 65 therapeutic categories, over 40 dosage forms. The company has 34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.
The stock of Cipla was trading marginally higher at Rs 393 on the Bombay Stock Exchange.
GoodReturns.in
Story first published: Thursday, December 5, 2013, 10:33 [IST]
More From GoodReturns
